Paul Simms
Paul Simms
Latest posts from Paul:
A new decade is here. And despite the incredible science, pharma is...
Celebrating winners makes genuine innovation visible, setting the bar higher...
From site-in-a-box to virtual/siteless trials: which new model will...
How patients taught me that pharma’s partnership efforts simply aren’t...
You don't have to give your data away for free. In fact, it is in...
eyeforpharma Chairman, Paul Simms, explains why pharma companies are failing to...
After decades in the shadows, companies are looking again at the key account...
One year on, Brent Saunders of Allergan suggests to Paul Simms the case for...
An interview with the team behind the MOSKI KIT, a Sanofi tool against malaria.
Søren Eik Skovlund is changing the conversation about diabetes patients’...